We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Extracorporeal membrane oxygenation in 34 days old infant with SARS-COV-2 associated pneumonia.
- Authors
Zhuk, Aleh; Tsylko, Aliaksei; Nazarava, Viktoryia; Migun, Anna
- Abstract
We present a case of successful veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in infant with SARS-COV-2 associated pneumonia. To the best of our knowledge, this patient was the youngest infant successfully discharged after the VA-ECMO for COVID-19. We report one complication of ECMO support, which was bleeding from the site of the radial artery cannulation. We followed up this patient for 6 months after the discharge: delayed psychomotor development and inability to swallow were noted. Follow-up CT 3 months after the discharge showed linear fibrosis of S5 lung segment.
- Subjects
PNEUMONIA treatment; HEMORRHAGE risk factors; PNEUMONIA; FLUCONAZOLE; EXTRACORPOREAL membrane oxygenation; PATIENTS; FUROSEMIDE; LOW-molecular-weight heparin; NEONATAL intensive care units; HOSPITAL admission &; discharge; CARDIOTONIC agents; OXYGEN therapy; IMMUNOGLOBULINS; HEPARIN; DRUG therapy; DISCHARGE planning; NEONATAL intensive care; ADRENALINE; HIGH-frequency ventilation (Therapy); NUCLEOTIDES; ROUTINE diagnostic tests; ENOXAPARIN; NORADRENALINE; LINEZOLID; DOPAMINE; VASOCONSTRICTORS; METHYLPREDNISOLONE; COVID-19; MEROPENEM; CULTURES (Biology); PATIENT aftercare; DEXAMETHASONE
- Publication
Perfusion, 2024, Vol 39, Issue 5, p1014
- ISSN
0267-6591
- Publication type
Article
- DOI
10.1177/02676591231169853